Solid Dosage
Anti-virals
GEA supplies solutions for manufacturing inhalable and oral antiviral drugs ranging from blending, spray drying and particle engineering to continuous manufacturing.
Manufacturing Anti-virals
Antiviral medications help the body to fight off harmful viruses such as influenza, chickenpox and the human immunodeficiency virus (HIV), to name a few. The drugs can ease symptoms and shorten the length of a viral infection. Antivirals also lower the risk of getting or spreading viruses that cause herpes and HIV. One approved antiviral treats the coronavirus that causes COVID-19.
Antiviral drugs are also preventive. They can protect you from getting viral infections or spreading a virus to others. They come in many formats, including tablets, intravenous solutions, liquids and inhaled powders.
For inhalable versions, GEA understands that homogeneity and stability are key factors. Our dry powder blending, spray drying and particle engineering capabilities ensure that the production of free-flowing, aerodynamic particles at the correct size is achievable at the scale you need.
And, with the ongoing development of oral anti-viral medications, particularly as a result of the COVID-19, pandemic, there is increased interest in the use of continuous manufacturing to accelerate process design and product optimization.
For example, the compact and fully integrated ConsiGma®4.0 platform has been designed to transfer powder into coated tablets in a shorter time frame. Plus, by combining Quality by Design (QbD) principles with Design of Experiments (DoE), it enables operators to explore the design space in a quick and easy way and expedite time-to-market.
المنتجات والتقنيات
يتم عرض 4 من 26
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Continuous Processing Lines for Pharma
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Downloads
رؤى GEA
الحقبة التالية لإنتاج الغذاء مع GEA NEXUS
يضع تغير المناخ والنمو السكاني العالمي ضغوطًا متزايدة على صناعة الأغذية كثيفة الاستهلاك للطاقة لإطعام المزيد من الناس دون الإضرار بالكوكب، ويشرح جورج شيبرد، مدير تكنولوجيا الاستدامة العالمية في GEA، كيف تستخدم GEA خبرتها الهندسية لمساعدة المعالجات على الإنتاج بشكل أكثر استدامة مع زيادة الإنتاجية.
Making milk production more sustainable for a growing world
The world's population is growing and with it demand for milk. Dairy is an essential component of many global diets. However, its production can be resource-intensive and impact the environment. GEA’s Christian Müller, Senior Director Sustainability Farm Technologies, sheds light on how technological innovations powered by GEA make milk production more efficient and profitable.
آلات نظيفة، غذاء آمن: قوة التصميم النظيف صحيًا
كل مشروب آمن وكل قضمة من غذاء هما انتصار على التهديدات الميكروبية غير المرئية - وهي معركة تشكلت على مدار قرن من تصميم عمليات المعالجة النظيفة صحيًا. تضع GEA معيار الصناعة لمعدات المعالجة التي تحمي الأغذية وتنقذ الأرواح، وذلك بفضل أكثر من 100 عام من الخبرة في الهندسة والمعرفة بالتصميم النظيف صحيًا.
